WuXi Biologics (Cayman) Inc. (HKG: 2269)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
15.18
-0.90 (-5.60%)
Nov 14, 2024, 4:08 PM HKT

WuXi Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
61,645124,993252,882390,943419,914127,705
Upgrade
Market Cap Growth
-69.97%-50.57%-35.31%-6.90%228.82%107.71%
Upgrade
Enterprise Value
60,597122,776247,673380,146418,224124,541
Upgrade
Last Close Price
15.0229.6059.8592.55102.8032.88
Upgrade
PE Ratio
23.3034.7752.4297.92216.40117.58
Upgrade
Forward PE
14.4022.6637.4177.91168.1580.23
Upgrade
PS Ratio
3.386.6614.6530.9563.0028.66
Upgrade
PB Ratio
1.432.586.189.7416.928.85
Upgrade
P/TBV Ratio
1.152.966.7810.5617.699.37
Upgrade
P/FCF Ratio
-182.37----
Upgrade
P/OCF Ratio
13.8524.3140.3792.82187.9594.50
Upgrade
PEG Ratio
1.681.381.031.993.921.75
Upgrade
EV/Sales Ratio
3.296.5414.3530.1062.7527.95
Upgrade
EV/EBITDA Ratio
11.9122.6143.2285.50198.8297.54
Upgrade
EV/EBIT Ratio
16.3528.3450.3697.69234.41117.44
Upgrade
EV/FCF Ratio
-180.77179.13----
Upgrade
Debt / Equity Ratio
0.100.100.120.130.160.17
Upgrade
Debt / EBITDA Ratio
0.960.890.861.181.851.88
Upgrade
Debt / FCF Ratio
-7.33----
Upgrade
Asset Turnover
0.320.320.330.280.240.30
Upgrade
Inventory Turnover
5.355.044.313.944.157.42
Upgrade
Quick Ratio
2.402.351.551.852.492.93
Upgrade
Current Ratio
2.912.781.982.373.163.37
Upgrade
Return on Equity (ROE)
7.20%8.90%13.20%13.09%10.02%9.67%
Upgrade
Return on Assets (ROA)
3.98%4.63%5.81%5.43%4.03%4.39%
Upgrade
Return on Capital (ROIC)
4.61%5.51%7.00%6.47%4.78%5.13%
Upgrade
Earnings Yield
5.90%3.00%1.98%1.06%0.48%0.89%
Upgrade
FCF Yield
-0.70%0.55%-0.15%-0.97%-1.17%-1.75%
Upgrade
Buyback Yield / Dilution
1.28%0.62%1.04%-5.05%-5.30%-1.41%
Upgrade
Total Shareholder Return
1.28%0.62%1.04%-5.05%-5.30%-1.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.